Reasons to be cheerful are scant
Their uprising could be the beginning of the end of Iran’s theocracy
The country’s clean-energy push shows a way to escape the coal addiction
Britain’s political fever dream continued apace this week as Rishi Sunak became prime minister without anyone even voting for him. The former chancellor, the country’s third prime minister in less than two months and the fifth in six years, is also the UK’s first leader of colour and the first Hindu to take the office.
Jonathan Freedland considers how big a blow Truss’s ill-judged stint in power has delivered to the school of neoliberal economic thought.
Brazil also faces a judgment day this weekend, as Jair Bolsonaro and Luiz Inácio Lula da Silva square up in a presidential runoff of deep significance for the country and the planet, with the protection of the Amazon at stake. The outcome is on such a knife-edge that not even the nation’s gangsters can decide who to vote for, as our Latin America correspondent Tom Phillips reports.
On the subject of the environment, don’t miss Naomi Klein’s long read about how Egypt’s government has used the coming Cop27 conference to greenwash its own oppressive political activities.
Then, there’s a revealing interview with Chelsea Manning, who opens up to Emma Brockes on what really happened when she leaked thousands of classified US military documents.
Miami’s skyscraper boom is happening on the frontlines of the climate crisis.
Miami, city, seat (1844) of Miami-Dade county, southeastern Florida, U.S. A major transportation and business hub, Miami is a leading resort and Atlantic Ocean port situated on Biscayne Bay at the mouth of the Miami River. The Everglades area is a short distance to the west. Greater Miami, the state’s largest urban concentration, comprises all of the county, which includes the cities of Miami Beach (across the bay), Coral Gables, Hialeah, North Miami, and many smaller municipalities and unincorporated areas; together, these make up the southern section of Florida’s “Gold Coast.”
The land beneath our feet is what sustains us – from it we can produce food, construct shelter and build livelihoods. But, it’s also a cultural marker and a source of identity. Its control has been a long-favoured tool of colonizers, wealth hoarders and polluters, while its fiercest protectors – often Indigenous peoples – are criminalized, violated and dispossessed. This edition hears from struggles to take back the land in Brazil, Bangladesh, Kenya and North America. We also launch our new series ‘Decolonize how?’ which will explore what people are doing to dismantle the impacts – and current realities – of British-linked colonialism.
Inside the Tufts Health & Nutrition Letter – November 2022:
Charles Glass – Although World War Three had come perilously close, Martin Indyk absolves Henry Kissinger: Soviet actions were ‘yet again characterised by an ultimate timidity in the face of American resolve’. ‘Resolve’ is one way of describing the risk of nuclear Armageddon. Another is ‘recklessness’.
Susan Pedersen – The problem with individual conscientious objection is that we are mutually dependent whether we acknowledge it or not. You may refuse to get vaccinated on grounds of conscience but will benefit from herd immunity if others do; you may refuse to pay taxes but will still get your rubbish collected; you may refuse to take up arms in war but will be protected from harm if others serve.
James Meek – If an innocuous merchant ship passing through the Baltic or the North Sea had a handful of ordinary, secretly armed trucks lashed to its deck, would any Nato country notice? Would the drones be detected or intercepted? If they were launched and hit their targets, could it ever be proven where they originated? As a threat to Europe, this is creative licence. But using swarms of Shahed-136s and other forms of missile to destroy a country’s energy system, on the eve of winter, is exactly what Russia is doing to Ukraine.
Abbott Laboratories newest continuous glucose monitor is now available at participating retail pharmacies and through durable medical equipment suppliers. The Freestyle Libre 3 was approved by the FDA in June and is a step up from previous Abbott systems.
Abbott Laboratories and Dexcom are the leaders in the CGM market, which hit $5.1 billion in revenue in 2021 and is expected to reach $13.2 billion by 2028, according to Vantage Market Research. Abbott’s CGM systems, called FreeStyle Libre, generated $3.7 billion in revenue last year, with 4 million users globally.
CNBC’s Erin Black, a type 1 diabetic, tested out the Libre 3 for over a month. Here is her review.
Boomers Daily 